edoc

Items where Author is "Ntinginya, Nyanda E."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2019 | 2018 | 2016 | 2015 | 2014
Number of items: 7.

2019

Tweed, Conor D. and Dawson, Rodney and Burger, Divan A. and Conradie, Almari and Crook, Angela M. and Mendel, Carl M. and Conradie, Francesca and Diacon, Andreas H. and Ntinginya, Nyanda E. and Everitt, Daniel E. and Haraka, Frederick and Li, Mengchun and van Niekerk, Christo H. and Okwera, Alphonse and Rassool, Mohammed S. and Reither, Klaus and Sebe, Modulakgotla A. and Staples, Suzanne and Variava, Ebrahim and Spigelman, Melvin. (2019) Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. The lancet Respiratory medicine, 7 (12). pp. 1048-1058.

2018

Sabi, Issa and Rachow, Andrea and Mapamba, Daniel and Clowes, Petra and Ntinginya, Nyanda E. and Sasamalo, Mohamed and Kamwela, Lujeko and Haraka, Frederick and Hoelscher, Michael and Paris, Daniel H. and Saathoff, Elmar and Reither, Klaus. (2018) Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study. The Journal of infection, 77 (4). pp. 321-327.

2016

Pohl, Christian and Rutaihwa, Liliana K. and Haraka, Frederick and Nsubuga, Martin and Aloi, Francesco and Ntinginya, Nyanda E. and Mapamba, Daniel and Heinrich, Norbert and Hoelscher, Michael and Marais, Ben J. and Jugheli, Levan and Reither, Klaus. (2016) Limited value of whole blood Xpert(®) MTB/RIF for diagnosing tuberculosis in children. The journal of infection, 73 (4). pp. 326-335.

Stucki, David and Brites, Daniela and Jeljeli, Leïla and Coscolla, Mireia and Liu, Qingyun and Trauner, Andrej and Fenner, Lukas and Rutaihwa, Liliana and Borrell, Sonia and Luo, Tao and Gao, Qian and Kato-Maeda, Midori and Ballif, Marie and Egger, Matthias and Macedo, Rita and Mardassi, Helmi and Moreno, Milagros and Vilanova, Griselda Tudo and Fyfe, Janet and Globan, Maria and Thomas, Jackson and Jamieson, Frances and Guthrie, Jennifer L. and Asante-Poku, Adwoa and Yeboah-Manu, Dorothy and Wampande, Eddie and Ssengooba, Willy and Joloba, Moses and Boom, W. Henry and Basu, Indira and Bower, James and Saraiva, Margarida and Vasconcellos, Sidra E. G. and Suffys, Philip and Koch, Anastasia and Wilkinson, Robert and Gail-Bekker, Linda and Malla, Bijaya and Ley, Serej D. and Beck, Hans-Peter and de Jong, Bouke C. and Toit, Kadri and Sanchez-Padilla, Elisabeth and Bonnet, Maryline and Gil-Brusola, Ana and Frank, Matthias and Penlap Beng, Veronique N. and Eisenach, Kathleen and Alani, Issam and Ndung'u, Perpetual Wangui and Revathi, Gunturu and Gehre, Florian and Akter, Suriya and Ntoumi, Francine and Stewart-Isherwood, Lynsey and Ntinginya, Nyanda E. and Rachow, Andrea and Hoelscher, Michael and Cirillo, Daniela Maria and Skenders, Girts and Hoffner, Sven and Bakonyte, Daiva and Stakenas, Petras and Diel, Roland and Crudu, Valeriu and Moldovan, Olga and Al-Hajoj, Sahal and Otero, Larissa and Barletta, Francesca and Carter, E. Jane and Diero, Lameck and Supply, Philip and Comas, Iñaki and Niemann, Stefan and Gagneux, Sebastien. (2016) Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nature genetics, 48 (12). pp. 1535-1543.

2015

Dawson, Rodney and Diacon, Andreas H. and Everitt, Daniel and van Niekerk, Christo and Donald, Peter R. and Burger, Divan A. and Schall, Robert and Spigelman, Melvin and Conradie, Almari and Eisenach, Kathleen and Venter, Amour and Ive, Prudence and Page-Shipp, Liesl and Variava, Ebrahim and Reither, Klaus and Ntinginya, Nyanda E. and Pym, Alexander and von Groote-Bidlingmaier, Florian and Mendel, Carl M.. (2015) Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment : a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet, Vol. 385, no. 9979. pp. 1738-1747.

Portevin, Damien and Moukambi, Félicien and Mpina, Maxmillian and Bauer, Asli and Haraka, Frederick and Chachage, Mkunde and Metzger, Philipp and Saathoff, Elmar and Clowes, Petra and Ntinginya, Nyanda E. and Rachow, Andrea and Hoelscher, Michael and Reither, Klaus and Daubenberger, Claudia A. and Geldmacher, Christof. (2015) Maturation and mip-1β production of cytomegalovirus-specific T cell responses in Tanzanian children, adolescents and adults : impact by HIV and Mycobacterium tuberculosis co-infections. PLoS ONE, Vol. 10, H. 5 , e0126716.

2014

Portevin, Damien and Moukambi, Felicien and Clowes, Petra and Bauer, Asli and Chachage, Mkunde and Ntinginya, Nyanda E. and Mfinanga, Elirehema and Said, Khadija and Haraka, Frederick and Rachow, Andrea and Saathoff, Elmar and Mpina, Maximilian and Jugheli, Levan and Lwilla, Fred and Marais, Ben J. and Hoelscher, Michael and Daubenberger, Claudia and Reither, Klaus and Geldmacher, Christof. (2014) Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children : a prospective proof-of-concept study. The Lancet infectious diseases, Vol. 14, H. 10. pp. 931-938.

This list was generated on Wed Apr 24 01:04:31 2024 CEST.